Epigenetic testing opens new doors for multiple myeloma treatment

Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the porous structure within the bones that produces normal blood cells, is invaded by an overgrowth of the so-called plasma cells. These cells, which in healthy conditions are part of the immune system and help prevent infections, have been transformed and, in addition to destroying the bone marrow, end up escaping and causing lesions in other locations such as the spine, skull, pelvis and ribs.

Source:

Josep Carreras Leukaemia Research Institute

Journal reference: